This multimodal MRI study identifies brain structure changes linked to cognitive decline in Parkinson's disease patients, highlighting implications for neural circuit dysfunction.
Cognitive trajectories in Parkinson's disease (PD) exhibit substantial heterogeneity, ranging from long-term stability to rapid decline. The specific neural circuit dysfunctions underlying these distinct outcomes remain unclear. Utilizing magnetic resonance imaging (MRI) data from the Parkinson's Progression Markers Initiative cohort, we employed voxel-based morphometry and free-water imaging to analyze baseline and longitudinal changes in gray matter volume (GMV) and white matter microstructure over a four-year period in cognitively normal (PD-NC) and cognitively impaired (PD-CI) PD patients. Machine learning models were then used to integrate clinical, neuroimaging, and fluid biomarker data to explore factors associated with cognitive decline. At baseline, PD-NC patients exhibited larger GMV in six cerebellar regions compared to healthy controls. Longitudinally, PD-CI patients showed accelerated GMV loss in seven regions, including the thalamus and temporal lobes. Notably, baseline cerebellar GMV and longitudinal thalamic atrophy rates emerged as factors associated with steeper cognitive decline. Exploratory free-water analysis revealed that PD-CI patients exhibited altered macro-microstructural relationships in the thalamus. These findings implicate the cerebello–thalamo–cortical (CTC) circuit in the heterogeneity of cognitive decline in PD, with cerebellar structure and thalamic atrophy showing differential associations with cognitive trajectories. They further underscore the value of integrating longitudinal structural and microstructural measures to characterize disease-related cognitive changes. • Multimodal longitudinal imaging identifies cerebello–thalamo–cortical (CTC) circuit involvement in PD cognitive heterogeneity. • Thalamic atrophy and cognitive trajectories emerge as the most robust findings across analyses. • Accelerated thalamic and temporal atrophy is associated with faster cognitive decline. • Strengths of this study include the large sample size, extended longitudinal follow-up, and standardized neuropsychological assessment.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: